US Patent Issued to HEM PHARMA on Sept. 30 for "Strain of Lactobacillus sakei HEM224, and composition for treating inflammation or asthma comprising strain or cultured product thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,620, issued on Sept. 30, was assigned to HEM PHARMA INC. (Pohang-si, South Korea).

"Strain of Lactobacillus sakei HEM224, and composition for treating inflammation or asthma comprising strain or cultured product thereof" was invented by Yo Sep Ji (Suwon-si, South Korea) and So Young Park (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a strain of Lactobacillus sakei HEM224 (KCTC14065BP) and a composition for treating, preventing or alleviating inflammation or asthma, comprising the strain. A strain of Lactobacillus sakei HEM224 (KCTC14065BP) according to an embodiment of the present disclosure...